Life-threatening cryoglobulinemic patients with hepatitis C: Clinical description and outcome of 279 patients

Medicine (United States)

Volumn 92, Issue 5, 2013, Pages 273-284

  Retamozo, Soledad ^a   Díaz Lagares, Cándido ^a   Bosch, Xavier ^b   Bové, Albert ^a   Brito Zerón, Pilar ^a   Gómez, Maria Eugenia ^a   Yagüe, Jordi ^b   Forns, Xavier ^b   Cid, Maria C ^b   Ramos Casals, Manuel ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; NEUTROPHIL CYTOPLASMIC ANTIBODY; RIBAVIRIN; RITUXIMAB;

ABDOMINAL PAIN; APPARENT LIFE THREATENING EVENT; ARTICLE; BRAIN DISEASE; BRAIN HEMORRHAGE; CAUSE OF DEATH; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC KIDNEY FAILURE; COMA; CORTICOSTEROID THERAPY; CRYOGLOBULINEMIA; DYSARTHRIA; FEVER; FOLLOW UP; GLOMERULONEPHRITIS; HEMATEMESIS; HEMIPLEGIA; HEMOPTYSIS; HEPATITIS B; HEPATITIS C; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMITTENT CLAUDICATION; INTESTINE ISCHEMIA; INTESTINE PERFORATION; ISCHEMIA; KIDNEY BIOPSY; KIDNEY FAILURE; LUNG HEMORRHAGE; MEDLINE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MIXED CONNECTIVE TISSUE DISEASE; MIXED INFECTION; MORTALITY; MYELITIS; NEOPLASM; NERVOUS SYSTEM INJURY; PANCREATITIS; PARAPLEGIA; PERIPHERAL NEUROPATHY; PLASMAPHERESIS; POLYARTERITIS NODOSA; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PURPURA; PYRAMIDAL SIGN; RAYNAUD PHENOMENON; RECTUM HEMORRHAGE; RELAPSE; RHEUMATOID ARTHRITIS; SEPSIS; SJOEGREN SYNDROME; SPASTICITY; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS;

EID: 84887997688     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0b013e3182a5cf71     Document Type: Article

References (100)

1. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med. 1992;327:1490-1495.
2. Aktipi KM, Ravaglia S, Ceroni M, Nemni R, Debiaggi M, Bastianello S, Alfonsi E, Zardini E, Minoli L, Tavazzi E, Marchioni E. Severe recurrent myelitis in patients with hepatitis C virus infection. Neurology. 2007;68:468-469.
3. Amital H, Rubinow A, Naparstek Y. Alveolar hemorrhage in cryoglobulinemia an indicator of poor prognosis. Clin Exp Rheumatol. 2005;23:616-620.
4. Bartolucci P, Ramanoelina J, Cohen P, Mahr A, Godmer P, Le Hello C, Guillevin L. Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients. Rheumatology (Oxford). 2002;41:1126-1132.
5. Basse G, Ribes D, Kamar N, Mehrenberger M, Sallusto F, Esposito L, Guitard J, Lavayssiere L, Oksman F, Durand D, Rostaing L. Rituximab therapy for de novo mixed cryoglobulinemia in renal transplant patients. Transplantation. 2005;80:1560-1564.
6. Beddhu S, Bastacky S, Johnson JP. The clinical and morphologic spectrum of renal cryoglobulinemia. Medicine (Baltimore). 2002;81:398-409.
7. Bestard O, Cruzado JM, Ercilla G, Goma M, Torras J, Seron D, Rama I, Ibernon M, Vinas O, Carrera M, Grinyo JM. Rituximab induces regression of hepatitis C virus-related membranoproliferative glomerulonephritis in a renal allograft. Nephrol Dial Transplant. 2006;21:2320-2324.
8. Bruchfeld A, Lindahl K, Stahle L, Soderberg M, Schvarcz R. Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency. Nephrol Dial Transplant. 2003;18: 1573-1580.
9. Buccoliero R, Gambelli S, Sicurelli F, Malandrini A, Palmeri S, De Santis M, Stromillo ML, De Stefano N, Sperduto A, Musumeci SA, Federico A. Leukoencephalopathy as a rare complication of hepatitis C infection. Neurol Sci. 2006;27:360-363.
10. Cacoub P, Saadoun D, Limal N, Sene D, LidoveO, Piette JC. PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum. 2005;52:911-915.
11. Cai FZ, Ahern M, Smith M. Treatment of cryoglobulinemia associated peripheral neuropathy with rituximab. J Rheumatol. 2006; 33:1197-1198.
12. Canada R, Chaudry S, Gaber L, Waters B, Martinez A, Wall B. Polyarteritis nodosa and cryoglobulinemic glomerulonephritis related to chronic hepatitis C. Am J Med Sci. 2006;331:329-333.
13. Casato M, Saadoun D, Marchetti A, Limal N, Picq C, Pantano P, Galanaud D, Cianci R, Duhaut P, Piette JC, Fiorilli M, Cacoub P. Central nervous system involvement in hepatitis C virus cryoglobulinemia vasculitis: a multicenter case-control study using magnetic resonance imaging and neuropsychological tests. J Rheumatol. 2005;32:484-488.
14. Casian A, Jayne D. Management of alveolar hemorrhage in lung vasculitides. Semin Respir Crit Care Med. 2011;32:335-345.
15. ChandesrisMO, Gayet S, Schleinitz N, Doudier B, Harle JR, Kaplanski G. Infliximab in the treatment of refractory vasculitis secondary to hepatitis C-associated mixed cryoglobulinaemia. Rheumatology (Oxford). 2004;43:532-533.
16. Cheng JT, Anderson HL Jr, Markowitz GS, Appel GB, Pogue VA, D'Agati VD. Hepatitis C virus-associated glomerular disease in patients with human immunodeficiency virus coinfection. J Am Soc Nephrol. 1999;10:1566-1574.
17. Chepyala P, Velchala N, Brown D, Olden K. Encephalopathy, a rare initial presentation of HCV related cryoglobulinemia. Am J Gastroenterol. 2009;104:S289.
18. D'Amico G. Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int. 1998;54:650-671.
19. Daoud MS, El-Azhary RA, Gibson LE, Lutz ME, Daoud S. Chronic hepatitis C, cryoglobulinemia, and cutaneous necrotizing vasculitis. Clinical, pathologic, and immunopathologic study of twelve patients. J Am Acad Dermatol. 1996;34:219-223.
20. Della Rossa A, Marchi F, Catarsi E, Tavoni A, Bombardieri S. Mixed cryoglobulinemia and mortality: a review of the literature. Clin Exp Rheumatol. 2008;26(5 Suppl 51):S105-S108.
21. Della Rossa A, Tavoni A, D'Ascanio A, Catarsi E, Marchi F, Bencivelli W, Salvadori S, Migliorini P, Bombardieri S. Mortality rate and outcome factors in mixed cryoglobulinaemia: the impact of hepatitis C virus. Scand J Rheumatol. 2010;39:167-170.
22. De Vita S, Quartuccio L, Isola M, Mazzaro C, Scaini P, Lenzi M, Campanini M, Naclerio C, Tavoni A, Pietrogrande M, Ferri C, Mascia MT, Masolini P, Zabotti A, Maset M, Roccatello D, Zignego AL, Pioltelli P, Gabrielli A, Filippini D, Perrella O, Migliaresi S, Galli M, Bombardieri S, Monti G. A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. Arthritis Rheum. 2012;64:843-853.
23. De Vita S, Soldano F, Isola M, Monti G, Gabrielli A, Tzioufas A, Ferri C, Ferraccioli GF, Quartuccio L, Corazza L, De Marchi G, Ramos Casals M, Voulgarelis M, Lenzi M, Saccardo F, Fraticelli P, Mascia MT, Sansonno D, Cacoub P, Tomsic M, Tavoni A, Pietrogrande M, Zignego AL, Scarpato S, Mazzaro C, Pioltelli P, Steinfeld S, Lamprecht P, Bombardieri S, Galli M. Preliminary classification criteria for the cryoglobulinaemic vasculitis. Ann Rheum Dis. 2011;70:1183-1190.
24. Dhib M, Francois A, Godin M. Gallbladder vasculitis and mixed cryoglobulinemia. Histopathology. 1994;25:399-400.
25. Dussol B, Moal V, Daniel L, Pain C, Berland Y. Spontaneous remission of HCV-induced cryoglobulinaemic glomerulonephritis. Nephrol Dial Transplant. 2001;16:156-159.
26. Engel P, Gomez-Puerta JA, Ramos-Casals M, Lozano F, Bosch X. Therapeutic targeting of B cells for rheumatic autoimmune diseases. Pharmacol Rev. 2011;63:127-156.
27. Erro Aguirre ME, Ayuso Blanco T, Tunon Alvarez T, Herrera Isasi M. Brain hemorrhage as a complication of chronic hepatitis C virus-related vasculitis. J Neurol. 2008;255:944-945.
28. Feld JJ, Hoofnagle JH. Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature. 2005;436:967-972.
29. Ferri C. Mixed cryoglobulinemia. Orphanet J Rare Dis. 2008;3:25.
30. Ferri C, Greco F, Longombardo G, Palla P, Moretti A, Marzo E, Fosella PV, Pasero G, Bombardieri S. Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia. Arthritis Rheum. 1991; 34:1606-1610.
31. Ferri C, Sebastiani M, Giuggioli D, Cazzato M, Longombardo G, Antonelli A, Puccini R, Michelassi C, Zignego AL. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum. 2004;33:355-374.
32. Filippini D, Colombo F, Jann S, Cornero R, Canesi B. Central nervous system involvement in patients with HCV-related cryoglobulinemia: literature review and a case report. Reumatismo. 2002;54:150-155.
33. Fine GD, Trainer TD, Krawitt EL. Gastrointestinal bleeding, cryoglobulinemia, and hepatitis C. Am J Gastroenterol. 2004;99:964-965.
34. Foessel L, Besancenot JF, Blaison G, Magy-Bertrand N, Jaussaud R, Etienne Y, Maurier F, Audia S, Martin T. Clinical spectrum, treatment, and outcome of patients with type II mixed cryoglobulinemia without evidence of hepatitis C infection. J Rheumatol. 2011;38:716-722.
35. Fragoso M, Carneado J, Tuduri I, Jimenez-Ortiz C. Essential mixed cryoglobulinemia as a cause of ischemic cerebrovascular accident. Rev Neurol. 2000;30:444-446.
36. Garini G, Allegri L, Carnevali ML, Iannuzzella F, Buzio C. Successful treatment of severe/active cryoglobulinaemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection by means of the sequential administration of immunosuppressive and antiviral agents. Nephrol Dial Transplant. 2006;21:3333-3334.
37. Geetha D, Seo P. Life-threatening presentations of ANCA-associated vasculitis. In: Khamashta MA, Ramos-Casals M, eds. Autoimmune Diseases. Acute and Complex Situations. London: Springer-Verlag; 2011:101-118.
38. Gomez-Tello V, Onoro-Canaveral JJ, de la Casa Monje RM, Gomez-Casero RB, Moreno Hurtrez JL, Garcia-Montes M, Armas LC. Diffuse recidivant alveolar hemorrhage in a patient with hepatitis C virus-related mixed cryoglobulinemia. Intensive Care Med. 1999;25:319-322.
39. Gournay J, Ferrell LD, Roberts JP, Ascher NL, Wright TL, Lake Jr. Cryoglobulinemia presenting after liver transplantation. Gastroenterology. 1996;110:265-270.
40. Guillevin L, Lhote F, Gayraud M, Cohen P, Jarrousse B, Lortholary O, Thibult N, Casassus P. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore). 1996;75:17-28.
41. Guillevin L, Pagnoux C. Indication for plasma exchange for systemic necrotizing vasculitides. Transfus Apher Sci. 2007;36:179-185.
42. Heckmann JG, Kayser C, Heuss D, Manger B, Blum HE, Neundorfer B. Neurological manifestations of chronic hepatitis C. J Neurol. 1999;246:486-491.
43. Iusova OI, Krivosheev OG, Semenkova EN, Kogan EA. Cryoglobulinemic vasculitis. Arkh Patol. 2000;62:51-54.
44. Izzedine H, Sene D, Cacoub P, Jansen H, Camous L, Brocheriou I, Bourry E, Deray G. Kidney diseases in HIV/HCV-co-infected patients. AIDS. 2009;23:1219-1226.
45. Johnson R, Gretch D, Couser WG, Alpers CE, Wilson J, Chung M, Hart J, Willson R. Hepatitis C virus-associated glomerulonephritis. Effect of >-interferon therapy. Kidney Int. 1994;46:1700-1704.
46. Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P, Couser WG, Corey L, Wener MH, Alpers CE, Willson R. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med. 1993;328:465-470.
47. Johnson SL, Bander J. Pulmonary hemorrhage in a patient with hepatitis C induced essential mixed cryoglobulinemia. Chest. 1998; 114:422S-425S.
48. Lamprecht P, Lerin-Lozano C, Merz H, Dennin RH, Gause A, Voswinkel J, Peters SO, Gutzeit O, Arlt AC, Solbach W, Gross WL. Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis. Ann Rheum Dis. 2003;62:1230-1233.
49. Lamprecht P, Moubayed P, Donhuijsen K, Gause A, Gross WL. Vasculitis of adnexa, greater omentum and gallbladder as abdominal manifestations of cryoglobulinemic vasculitis. Clin Exp Rheumatol. 2001;19:112-113.
50. Lamprecht P, Schmitt WH, Gross WL. Mixed cryoglobulinaemia, glomerulonephritis, and ANCA: essential cryoglobulinaemic vasculitis or ANCA-associated vasculitis? Nephrol Dial Transplant. 1998;13:213-221.
51. Landau DA, Scerra S, Sene D, Resche-Rigon M, Saadoun D, Cacoub P. Causes and predictive factors of mortality in a cohort of patients with hepatitis C virus-related cryoglobulinemic vasculitis treated with antiviral therapy. J Rheumatol. 2010;37:615-621.
52. Lozano Maya M, Aldeguer Martinez M, Banares Canizares R, Yepes Barreto I, Ponferrada Diaz A, Rodriguez Benitez P, Niembro de Rasche E, Cos Arregui E. Mixed cryoglobulinemia associated with hepatitis C virus. Diagnosis by transjugular renal biopsy. Rev Esp Enferm Dig. 2009;101:658-659.
53. Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, Savage C, Adu D. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. Q J Med. 1994;87:671-678.
54. Markowitz GS, Cheng JT, Colvin RB, Trebbin WM, D'Agati VD. Hepatitis C viral infection is associated with fibrillary glomerulonephritis and immunotactoid glomerulopathy. J Am Soc Nephrol. 1998;9:2244-2252.
55. Massari M, Catania A, Magnani G. Efficacy and risk of rituximab in type II mixed cryoglobulinemia: a significant case report. Dig Liver Dis. 2007;39:S134-S135.
56. Matignon M, Cacoub P, Colombat M, Saadoun D, Brocheriou I, Mougenot B, Roudot-Thoraval F, Vanhille P, Moranne O, Hachulla E, Hatron PY, Fermand JP, Fakhouri F, Ronco P, Plaisier E, Grimbert P. Clinical and morphologic spectrum of renal involvement in patients with mixed cryoglobulinemia without evidence of hepatitis C virus infection. Medicine (Baltimore). 2009;88:341-348.
57. Medina F, Ayala A, Jara LJ, Becerra M, Miranda JM, Fraga A. Acute abdomen in systemic lupus erythematosus: the importance of early laparotomy. Am J Med. 1997;103:100-105.
58. Meltzer M, Franklin EC. CryoglobulinemiaVa study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability. Am J Med. 1966;40:828-836.
59. Mendez P, Saeian K, Reddy KR, Younossi ZM, Kerdel F, Badalamenti S, Jeffers LJ, Schiff ER. Hepatitis C, cryoglobulinemia, and cutaneous vasculitis associated with unusual and serious manifestations. Am J Gastroenterol. 2001;96:2489-2493.
60. Misiani R, Bellavita P, Baio P, Caldara R, Ferruzzi S, Rossi P, Tengattini F. Successful treatment of HCV-associated cryoglobulinaemic glomerulonephritis with a combination of interferon-alpha and ribavirin. Nephrol Dial Transplant. 1999; 14:1558-1560.
61. Mohan S, Jaitly M, Cheng JT, D'Agati VD, Pogue VA. Unusual biopsy findings in a hepatitis C-infected white man with cryoglobulinemia, purpuric rash, and renal failure. Am J Kidney Dis. 2006;48:513-517.
62. Montagna G, Piazza V, Banfi G, Bellotti V, Segagni S, Picardi L, Mangione P, Giorgetti S, Zorzoli I, Cerino A, Salvadeo A. Hepatitis C virus-associated cryoglobulinaemic glomerulonephritis with delayed appearance of monoclonal cryoglobulinaemia. Nephrol Dial Transplant. 2001;16:432-434.
63. Monti G, Saccardo F. Emergency in cryoglobulinemic syndrome: what to do? Dig Liver Dis. 2007;39(Suppl 1):S112-S115.
64. Morales E, Alegre R, Herrero J, Morales J, Ortuno T, Praga M. Hepatitis-C-virus-associated cryoglobulinaemic membranoproliferative glomerulonephritis in patients infected by HIV. Nephrol Dial Transplant. 1997;12:1980-1984.
65. Morosetti M, Sciarra G, Meloni C, Palmieri G, Palombo G, Taccone Gallucci M, Casciani CU. Membranoproliferative glomerulonephritis and hepatitis C: effects of interferon-> therapy on clinical outcome and histological pattern. Nephrol Dial Transplant. 1996;11:532-534.
66. Moses P, Krawitt E, Aziz W, Corwin H. Renal failure associated with hepatitis C virus infection. Improvement in renal function after treatment with interferon-alpha. Dig Dis Sci. 1997;42:443-446.
67. Myers JP, Di Bisceglie AM, Mann ES. Cryoglobulinemia associated with Purtscher-like retinopathy. Am J Ophthalmol. 2001;131: 802-804.
68. Origgi L, Vanoli M, Carbone A, Grasso M, Scorza R. Central nervous system involvement in patients with HCV-related cryoglobulinemia. Am J Med Sci. 1998;315:208-210.
69. Perello Carbonel R, Supervia Caparros A, Nolla Salas J, Vazquez Sanchez A, Torrente Segarra V, Gutierrez Cebollada J. Alveolar haemorrhage and hepatitis virus C related mixed cryoglobulinemia. Report of three cases. An Med Interna. 2005;22:529-531.
70. Petty GW, Duffy J, Houston J III. Cerebral ischemia in patients with hepatitis C virus infection and mixed cryoglobulinemia. Mayo Clin Proc. 1996;71:671-678.
71. Prasad M, Buller G, Mena CI, Sofair AN. Sum of the parts. N Engl J Med. 2006;355:2468-2473.
72. Propst T, Propst A, Nachbauer K, Graziadei I, Willeit H, Margreiter R, Vogel W. Papillitis and vasculitis of the arteria spinalis anterior as complications of hepatitis C reinfection after liver transplantation. Transpl Int. 1997;10:234-237.
73. Quartuccio L, Petrarca A, Mansutti E, Pieroni S, Calcabrini L, Avellini C, Zignego A, De Vita S. Efficacy of rituximab in severe and mild abdominal vasculitis in the course of mixed cryoglobulinemia. Clin Exp Rheumatol. 2010;28:S84-S87.
74. Quartuccio L, Soardo G, Romano G, Zaja F, Scott CA, De Marchi G, Fabris M, Ferraccioli G, De Vita S. Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids. Rheumatology (Oxford). 2006;45:842-846.
75. Quigg RJ, Brathwaite M, Gardner DF, Gretch DR, Ruddy S. Successful cyclophosphamide treatment of cryoglobulinemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection. Am J Kidney Dis. 1995;25:798-800.
76. Ramos-Casals M, Font J. Extrahepatic manifestations in patients with chronic hepatitis C virus infection. Curr Opin Rheumatol. 2005;17: 447-455.
77. Ramos-Casals M, Robles A, Brito-Zeron P, Nardi N, Nicolas JM, Forns X, Plaza J, Yague J, Sanchez-Tapias JM, Font J. Life-threatening cryoglobulinemia: clinical and immunological characterization of 29 cases. Semin Arthritis Rheum. 2006;36:189-196.
78. Ramos-Casals M, Stone JH, Cid MC, Bosch X. The cryoglobulinaemias. Lancet. 2012;379:348-360.
79. Ramos-Casals M, Trejo O, Garcia-Carrasco M, Cervera R, Font J. Mixed cryoglobulinemia: new concepts. Lupus. 2000;9:83-91.
80. Retamozo S, Diaz-Lagares C, Bosch X, De Vita S, Ramos-Casals M. Life-threatening cryoglobulinemia. In: Khamashta MA, Ramos-Casals M, eds. Autoimmune Diseases. Acute and Complex Situations. London: Springer-Verlag; 2011:133-162.
81. Rieu V, Cohen P, Andre MH, Mouthon L, Godmer P, Jarrousse B, Lhote F, Ferriere F, Deny P, Buchet P, Guillevin L. Characteristics and outcome of 49 patients with symptomatic cryoglobulinaemia. Rheumatology (Oxford). 2002;41:290-300.
82. Roccatello D, Baldovino S, Rossi D, Mansouri M, Naretto C, Gennaro M, Cavallo R, Alpa M, Costanzo P, Giachino O, Mazzucco G, Sena LM. Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis. Nephrol Dial Transplant. 2004;19:3054-3061.
83. Roccatello D, Fornasieri A, Giachino O, Rossi D, Beltrame A, Banfi G, Confalonieri R, Tarantino A, Pasquali S, Amoroso A, Savoldi S, Colombo V, Manno C, Ponzetto A, Moriconi L, Pani A, Rustichelli R, Di Belgiojoso GB, Comotti C, Quarenghi MI. Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis. Am J Kidney Dis. 2007;49:69-82.
84. Rodriguez-Vidigal FF, Roig Figueroa V, Perez-Lucena E, Ledesma Jurado V, Ramirez Gurruchaga P, Aguilar Escobar FJ, Relea Calatayud MF, Baz MJ. EAlveolar hemorrhage in mixed cryoglobulinemia associated with hepatitis C virus infection. An Med Interna. 1998;15:661-663.
85. Roithinger FX, Allinger S, Kirchgatterer A, Prischl F, Balon R, Haidenthaler A, Knoflach P. A lethal course of chronic hepatitis C, glomerulonephritis, and pulmonary vasculitis unresponsive to interferon treatment. Am J Gastroenterol. 1995;90:1006-1008.
86. Rossi P, Bertani T, Baio P, Caldara R, Luliri P, Tengattini F, Bellavita P, Mazzucco G, Misiani R. Hepatitis C virus-related cryoglobulinemic glomerulonephritis: long-term remission after antiviral therapy. Kidney Int. 2003;63:2236-2241.
87. Saadoun D, Landau DA, Calabrese LH, Cacoub PP. Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation. Rheumatology (Oxford). 2007;46:1234-1242.
88. Saadoun D, Resche-Rigon M, Thibault V, Piette JC, Cacoub P. Antiviral therapy for hepatitis C virus associated mixed cryoglobulinemia vasculitis: a long-term follow-up study. Arthritis Rheum. 2006;54: 3696-3706.
89. Salamone F, Puzzo L. Intestinal HCV-related mixed cryoglobulinemia. Gastroenterology. 2010;138:e9-e10.
90. Sansonno D, Dammacco F. Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations. Lancet Infect Dis. 2005; 5:227-236.
91. Shibazaki K, Iguchi Y, Kimura K, Wada K, Ueno Y, Sunada Y. Paradoxical brain embolism associated with HCV-related type II mixed cryoglobulinemia. J Clin Neurosci. 2007;14:780-782.
92. Suzuki R, Morita H, Komukai D, Hasegawa T, Nakao N, Ideura T, Yoshimura A. Mixed cryoglobulinemia due to chronic hepatitis C with severe pulmonary involvement. Intern Med. 2003;42:1210-1214.
93. Tada M, Naruse S, Arai A, Sato A, Tanaka K, Piao YS, Kakita A, Takahashi H, Nishizawa M, Tsuji S. An autopsy case of systemic vasculitis associated with hepatitis C virus-related mixed cryoglobulinemia presenting severe peripheral neuropathy. Rinsho Shinkeigaku. 2004;44:686-690.
94. Tarantino A, Campise M, Banfi G, Confalonieri R, Bucci A, Montoli A, Colasanti G, Damilano I, D'Amico G, Minetti L, Ponticelli C. Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. Kidney Int. 1995;47:618-623.
95. Tembl JI, Ferrer JM, Sevilla MT, Lago A, Mayordomo F, Vilchez JJ. Neurologic complications associated with hepatitis C virus infection. Neurology. 1999;53:861-864.
96. Terrier B, Saadoun D, Sene D, Scerra S, Musset L, Cacoub P. Presentation and outcome of gastrointestinal involvement in hepatitis C virus-related systemic vasculitis: a case-control study from a single-centre cohort of 163 patients. Gut. 2010;59:1709-1715.
97. Trejo O, Ramos-Casals M, Garcia-Carrasco M, Yague J, Jimenez S, de la Red G, Cervera R, Font J, Ingelmo M. Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Medicine (Baltimore). 2001; 80:252-262.
98. Visentini M, Granata M, Veneziano ML, Borghese F, Carlesimo M, Pimpinelli F, Fiorilli M, Casato M. Efficacy of low-dose rituximab for mixed cryoglobulinemia. Clin Immunol. 2007;125:30-33.
99. Zaja F, De Vita S, Russo D, Michelutti A, Fanin R, Ferraccioli G, Baccarani M. Rituximab for the treatment of type II mixed cryoglobulinemia. Arthritis Rheum. 2002;46:2252-2254.
100. Zandman-Goddard G, Levy Y, Weiss P, Shoenfeld Y, Langevitz P. Transverse myelitis associated with chronic hepatitis C. Clin Exp Rheumatol. 2003;21:111-113.